PROTEOMONITOR SUBSCRIBERS: Troubled Waters: More Patent Lawsuits Threaten Company s Current Mass Specs

Dec 03, 2002

This article is available to subscribers of ProteoMonitor.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.